Killer cell immunoglobulin-like receptor 2DL1

BE0010669ProteinHumansKIR2DL1

Receptor on natural killer (NK) cells for some HLA-C alleles such as w4 and w6. It is acted on by 2 drugs in DrugBank.

Gene name
KIR2DL1
UniProtKB entry
P43626Swiss-Prot
Cellular location
Cell membrane
Residues / weight
348 residues · 38,579 Da
Also known as
CD158 antigen-like family member A · CD158A · Natural killer-associated transcript 1 · NKAT-1 · NKAT1

Resolves to

Protein
UniProtP43626UniProt nameKI2L1_HUMAN
Gene
HGNCHGNC:6329NCBI Gene3802GeneCardsKIR2DL1
Pharmacology
KEGGhsa:3802
Structure
PDB1IM9PDB1NKRPDB9F2D
Drugs

What you can answer from here — as of October 31, 2023

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Killer cell immunoglobulin-like receptor 2DL1, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In